Your browser doesn't support javascript.
loading
Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation.
Simic, Damir; Sang, Nianli.
Affiliation
  • Simic D; Department of Biology, Drexel University, Philadelphia, PA; Janssen R&D, Preclinical Development & Safety, Johnson & Johnson, Spring House, PA, USA.
  • Sang N; Department of Biology, Drexel University, Philadelphia, PA; Sidney Kimmel Cancer Center, Philadelphia, PA. Electronic address: nianli.sang@drexel.edu.
Exp Hematol ; 72: 36-46, 2019 04.
Article in En | MEDLINE | ID: mdl-30611870
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Megakaryocytes / Cell Differentiation / Histone Deacetylase Inhibitors / Hydroxamic Acids / Anilides Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Exp Hematol Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Megakaryocytes / Cell Differentiation / Histone Deacetylase Inhibitors / Hydroxamic Acids / Anilides Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Exp Hematol Year: 2019 Document type: Article Affiliation country: Country of publication: